Alternatives to Cognito Therapeutics
Cognito Therapeutics is a Biotechnology tool: developing a novel therapeutic approach for Alzheimer's disease. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotechnology companies to Cognito Therapeutics
- Website OPOptoCeutics52NeurotechnologyKongens Lyngby, Denmark$16.9M
OptoCeutics develops non-invasive light-based technology to stimulate the brain and improve cognitive function.
- GRGrey Matter Neurosciences40NeurotechnologyToronto, Canada$14.0M
Developing non-invasive ultrasound technology to treat age-related brain diseases like Alzheimer's.
- Website
Aviv Scientific54HealthcareTel Aviv, Israel$40.0MGlobal network of clinics using AI and data science to treat age-related cognitive and functional decline.
- Website
FIZE Medical38MedTechTel Aviv, Israel$30.0MFIZE Medical is developing a novel, non-invasive device for early detection of neurological diseases.
- Website SISinaptica Therapeutics0BiotechBoston, United States
Sinaptica Therapeutics is a biotechnology company developing novel therapies for neurodegenerative diseases, focusing on synaptic dysfunction.
- Website
ALZAI Health18HealthTechTel Aviv, IsraelAI-powered platform for early Alzheimer's detection and personalized care.
- Website
NRG Therapeutics42BiotechStevenage, United Kingdom$58.6MA biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website OROryon Cell Therapies62BiotechnologyBelmont, USA$21.0M
Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.
- Website
Supernus Pharmaceuticals60BiotechnologyRockville, United States$17.5MBiopharmaceutical company developing and commercializing CNS disease treatments.
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website
Spiderwort55BiotechnologyOttawa, Canada$16.2MBiotechnology company developing plant-based biomaterials for regenerative medicine and tissue engineering.
- Website
Neuralink75NeurotechnologyFremont, United States$650.0MDeveloping ultra-high bandwidth brain-machine interfaces to connect humans and computers.
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- CECellbricks Therapeutics53BiotechnologyBerlin, Germany$7.0M
Biofabrication platform for 3D-printed human tissue implants and future organ manufacturing.
- Website
SonoThera53BiotechnologySan Francisco, USA$125.0MDeveloping ultrasound-mediated nonviral genetic medicines.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website
Element Biosciences53BiotechnologySan Diego, USA$175.0MRevolutionizing genomic analysis with innovative sequencing technology.
- Website
En Carta Diagnostics52BiotechnologyParis, France$5.0MDeveloping a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.
- CECellply52BiotechnologyBologna, Italy$7.2M
DeepTech startup developing analytical tools for characterization of cancer immunotherapies, cell therapies, and cell-based biotherapeutics.
Showing the 20 closest matches. See the rest on the Cognito Therapeutics profile.
Compare Cognito Therapeutics head to head
Side by side on what each one does, what it costs, and what real users report.